Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Operating Leases (2020 - 2025)

Inspire Medical Systems' Operating Leases history spans 6 years, with the latest figure at $30.0 million for Q4 2025.

  • For Q4 2025, Operating Leases changed 0.14% year-over-year to $30.0 million; the TTM value through Dec 2025 reached $30.0 million, changed 0.14%, while the annual FY2025 figure was $30.0 million, 0.14% changed from the prior year.
  • Operating Leases for Q4 2025 was $30.0 million at Inspire Medical Systems, down from $33.1 million in the prior quarter.
  • Across five years, Operating Leases topped out at $33.1 million in Q2 2025 and bottomed at $7.2 million in Q1 2023.
  • The 5-year median for Operating Leases is $24.5 million (2024), against an average of $20.0 million.
  • The largest annual shift saw Operating Leases skyrocketed 240.99% in 2024 before it dropped 0.14% in 2025.
  • A 5-year view of Operating Leases shows it stood at $8.8 million in 2021, then grew by 0.86% to $8.9 million in 2022, then surged by 180.05% to $24.8 million in 2023, then grew by 20.9% to $30.0 million in 2024, then decreased by 0.14% to $30.0 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Operating Leases are $30.0 million (Q4 2025), $33.1 million (Q2 2025), and $30.0 million (Q4 2024).